GSK2801 CAS:1619994-68-1 is a potent, selective and cell-active acetyl-lysine-competitive inhibitor of the bromodomains of BAZ2A (Kd=136 nM) and BAZ2B (Kd=257 nM), GSK 2801 is selective for BAZ2A and BAZ2B inhibitors, Kd The values were 0.26 and 0.14 µM, respectively (IC50 values were 0.40 and 0.43 µM, respectively). GSK-2801 binds to the BAZ2 bromodomain with dissociation constants (KD) of 136 and 257 nM for BAZ2B and BAZ2A, respectively.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
![l-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-lHpyrazolo [3,4-d]pyrimidin-l-yl]-l-piperidinyl]-2-propyn-l-one](https://e1752fbe.rocketcdn.me/wp-content/uploads/AP14272-CAS-936563-91-6-1-e1686054563587.png)
